Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Intersect Strategies is a boutique communications and strategic consulting firm rather than a therapeutic developer. The company provides public relations, marketing, investor relations, public affairs, alliance development, patient engagement, and coalition-management services, with a stated focus across healthcare, biotech, clinical research, technology, financial services, and association clients. Its positioning appears centered on helping organizations tailor messaging for different stakeholders including investors, regulators, policymakers, employees, patients, and media. For biotech and healthcare clients, the firm looks most relevant as an external advisor supporting communications, advocacy, and market-facing strategy rather than drug discovery, clinical development, or manufacturing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Intersect Strategies.